USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 146 filers reported holding USANA HEALTH SCIENCES INC in Q2 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $37,000 | +208.3% | 500 | +150.0% | 0.01% | +66.7% |
Q1 2020 | $12,000 | -62.5% | 200 | -50.0% | 0.01% | -33.3% |
Q2 2019 | $32,000 | -96.1% | 400 | -95.9% | 0.01% | -91.7% |
Q1 2019 | $816,000 | +2300.0% | 9,800 | +3166.7% | 0.11% | +890.9% |
Q4 2018 | $34,000 | -58.0% | 300 | -57.1% | 0.01% | -38.9% |
Q2 2018 | $81,000 | +19.1% | 700 | -12.5% | 0.02% | +5.9% |
Q1 2018 | $68,000 | -60.7% | 800 | -73.3% | 0.02% | -55.3% |
Q3 2017 | $173,000 | -57.8% | 3,000 | -53.1% | 0.04% | -36.7% |
Q2 2017 | $410,000 | +494.2% | 6,400 | +433.3% | 0.06% | +650.0% |
Q1 2017 | $69,000 | -88.1% | 1,200 | -76.9% | 0.01% | -90.0% |
Q2 2016 | $579,000 | +6.0% | 5,200 | +15.6% | 0.08% | +27.0% |
Q1 2016 | $546,000 | -40.7% | 4,500 | -37.5% | 0.06% | -44.7% |
Q4 2015 | $920,000 | +185.7% | 7,200 | +200.0% | 0.11% | +208.1% |
Q3 2015 | $322,000 | – | 2,400 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |